Alixo-yolloo CORP
Market Movers (8-K)
OTC.Pink
Made in USA Inc. has completed an all-stock acquisition of intellectual property and operational infrastructure from Made in USA One LLC, valued at $25 million, to enhance its verification and supply-chain transparency platform.
OTC.Pink
Made in USA Inc. announced a non-binding term sheet with Rosalind, Inc. to form Rosalind Systems, Inc., a new entity focused on trusted healthcare and life sciences data infrastructure.
Capital raise
OTC.Pink
Steven K. Sprague has resigned as President of MADE IN USA INC., effective October 27, 2025, with no immediate replacement named.
OTC.Pink
MADE IN USA INC. announced a corporate name change, 4-for-1 forward stock split, symbol change, and relocation of its principal offices to Wyoming.
Delay expected
OTC.Pink
ALIXO-YOLLOO Corporation rebrands to Made in USA Inc. after a change of control, appointing new leadership to spearhead US manufacturing reshoring.
Delay expected
Capital raise
OTC.Pink
Alixo-Yolloo Corporation announced the appointment of Patryk Czerwinski, an experienced finance and corporate governance professional, as a new independent director to its Board of Directors, effective July 17, 2025.
Quarterly Earnings (10-Q)
OTC.Pink
Made in USA Inc. reports on its Q1 2026 performance, detailing a strategic pivot towards reshoring manufacturing and supply chain transparency, alongside a review of its financial condition.
Worse than expected
Capital raise
OTC.Pink
Made in USA Inc. reports a strategic pivot to U.S. manufacturing reshoring and supply chain authenticity, alongside significant financial challenges including a going concern doubt and ineffective disclosure controls.
Capital raise
Worse than expected
OTC.Pink
Made in USA Inc. reports Q2 net income amid a strategic pivot to US industrial reshoring, despite ongoing going concern doubts and zero cash reserves.
Capital raise
OTC.Pink
Alixo-Yolloo Corporation reported a significant 189% increase in revenue for the quarter ended May 31, 2025, driven by API package sales, but also saw a substantial rise in net losses and faces ongoing concerns about its ability to continue as a going concern due to insufficient capital and an accumulated deficit.
Capital raise
Worse than expected
OTC.Pink
Alixo-Yolloo Corporation's Q3 2025 filing reveals a net loss and highlights concerns about the company's ability to continue as a going concern.
Worse than expected
Capital raise
Annual Reports (10-K)
OTC.Pink
Alixo-Yolloo Corporation filed an amendment to its annual report, adjusting prior financial statements and disclosing increased net losses, significant internal control weaknesses, and substantial doubt about its ability to continue as a going concern, despite a 75% revenue increase.
Capital raise
Worse than expected
OTC.Pink
Alixo-Yolloo Corporation, a music recognition service provider, reported a 75% increase in revenue for fiscal year 2025, but also a 234% surge in net losses, raising substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
Delay expected
OTC.Pink
Alixo-Yolloo Corporation files an amendment to its annual report to reissue the independent auditor's report for the year ended February 28, 2023, and to rename certain line items in the financial statements.
Capital raise
Worse than expected
Schedule 13D - Activist Investments
OTC.Pink
Tax Credits International Inc. has filed a Schedule 13D reporting a 46.9% beneficial ownership stake in Made in USA Inc.
Capital raise
Schedule 13G - Passive Investments
OTC.Pink
Aspire Heights, LLC has filed a Schedule 13G reporting an 8.0% beneficial ownership stake in Made in USA Inc. common stock.